Nia Haware and Marcia Pennant work jointly as Legacy Marketing Officers in our Development and Communications Office.

Dr Gabriela Kramer-Marek’s group uses cutting-edge biomedical imaging techniques to gain information about the way particular genes drive cancer progression. Our group’s long-term goal is to develop ...

Professor Trevor Graham's group harnesses artificial intelligence and the principles of evolution with the aim of improving cancer prevention, diagnosis and treatment. Trevor Graham is Professor of ...

Thousands of people with cancer are currently taking part in our clinical trials. Where possible, each clinical trial page includes a link to a plain English summary. You can also find out more about ...

We want to make sure our trials are inclusive and accessible to everyone affected by cancer, no matter their background, ethnic group or personal circumstances. When designing trials we work with ...

Hormone replacement therapy taken at age 50 for up to 5 years only modestly increases the risk of breast cancer, even for women with a strong family history of the disease, according to a new risk ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...